John Moore

Mr Moore is executive with leadership experience across multiple industries. He currently serves on the boards of one private and two public companies. In the life sciences sector, he is Chairman of Scientific Industries, a manufacturer of laboratory instruments, and Trialogics, a clinical trial informatics company. Until July 23, 2026, John was a shareholder and director of Cormetech. Previously, he was CEO of Acorn Energy, where he led the acquisition of CoaLogix for 11 million dollars and its later sale for 101 million dollars. He also oversaw the public listing of Comverge through Citibank and exited through a secondary offering led by Goldman Sachs at a 600 million dollars valuation prior to its sale to Constellation Energy. Earlier, in 2002, he served as Partner and CEO of Edson Moore Healthcare Ventures, managing the 148 million dollars acquisition of 16 drug delivery investments from Elan Pharmaceuticals.